PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27966954-1	2017	The discovery of a novel potent type II ABL/c-KIT dual kinase inhibitor compound 34 (CHMFL-ABL/KIT-155), which utilized a hydrogen bond formed by NH on the kinase backbone and carbonyl oxygen of 34 as a unique hinge binding, is described.	Oxygen	185-191	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	44-49	
28271621-4	2017	c-KIT+ hAFS were isolated from leftover samples of amniotic fluid from prenatal screening and stimulated to enhance EV release (24 hours 20% O2 versus 1% O2 preconditioning).	Oxygen	141-143	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	0-5	
28271621-4	2017	c-KIT+ hAFS were isolated from leftover samples of amniotic fluid from prenatal screening and stimulated to enhance EV release (24 hours 20% O2 versus 1% O2 preconditioning).	Oxygen	154-156	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	0-5	
21674817-13	2011	Then, it was used to study c-kit expression of CD34+ cells at 5% O2, using 21%-O2 cultures as a control.	Oxygen	65-67	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	27-32	
27694215-0	2016	Physiological and hypoxic oxygen concentration differentially regulates human c-Kit+ cardiac stem cell proliferation and migration.	Oxygen	26-32	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	78-83